Inhibition of protein synthesis reduces the positive inotropic effect of ouabain

Area of Science:

• Pharmacology
• Molecular Biology
• Cardiovascular Physiology

Background:

• Cardiac glycosides like ouabain are known to have positive inotropic effects.
• The precise molecular mechanisms underlying ouabain's inotropic action are not fully elucidated.
• Protein synthesis involvement in drug action is a critical area of research.

Purpose of the Study:

• To investigate the role of protein synthesis in mediating the positive inotropic effect of ouabain.
• To determine if de novo protein synthesis is required for ouabain's cardiac effects.

Main Methods:

• Cardiac muscle strips (atria and ventricles) from guinea-pigs and rats were used.
• Pretreatment with cycloheximide (protein synthesis inhibitor) was performed in vivo.
• Actinomycin (transcription inhibitor) was added to the perfusion medium of isolated rat ventricle strips.
• The positive inotropic response to ouabain was measured after these treatments.

Main Results:

• Cycloheximide pretreatment significantly reduced or abolished the positive inotropic effect of ouabain in both guinea-pig and rat cardiac tissues.
• Actinomycin treatment of rat ventricle strips also diminished the response to ouabain.
• These findings indicate a dependency of ouabain's inotropic action on protein synthesis.

Conclusions:

• The positive inotropic effect of ouabain appears to require the synthesis of a short-lived protein.
• Alternatively, ouabain's action may involve the stimulation of protein synthesis.
• These results highlight the dynamic, protein-synthesis-dependent nature of ouabain's cardiac effects.